Mabgene is a biotechnology company engaged in the development and manufacture of recombinant proteins and monoclonal antibodies by using cell culture techniques on a contract basis. It provides production services using fully documented procedures and state-of-the-art technology by working in close collaboration with its clients for the mutual benefit of both parties. Mabgene is also specialized in the field of expression in different animal cell systems. It has purpose-built positive pressure laboratories specifically for cell growth optimization and the banking of Master and Manufacturers Working Cell Banks. In collaboration with independent testing laboratories, Mabgene is able to offer secure storage facilities, full cell line authentication and microbial QC testing to meet regulatory requirements. The company owns two distinctive production units one which comprises the stages of optimization and the production of biomolecules batches and the other cGMP production unit dedicated to the production of clinical batches. Mabgene is headquartered in Ales Cedex, France.

Street: 
Impasse des Chenes
City: 
Ales Cedex
Postcode: 
30319
Federal State : 
France
WebSite: 
www.mabgene.com
Fax: 
33-466-564089

Company Index Score

Current Index Score Historical Index Score
  • Mabgene currently scores 50 % in the index.
  • Mabgene is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Mabgene is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets